China's exports of pharmaceuticals increased by 6.3% year on year

According to the database of China Business Industry Research Institute, China's pharmaceutical exports grew moderately from January to March 2019 and from 2013 to 2018, with a total increase of 26.18%. China's exports of pharmaceuticals were 258,339 tons, an increase of 6.3% over the same period last year.
The amount of Chinese pharmaceutical exports showed an increasing trend from 2013 to 2018, and the growth rate increased; from November to March 2019, the amount of Chinese pharmaceutical exports was 4206.35 million US dollars, down 2.7% from the same period last year. %.
Looking for chemical products? Let suppliers reach out to you!
2026-06-02
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vivo Capital Co-founded! Xinrui Won Exclusive Rights to 4 RNAi Drugs in Greater China
-
What Are The Industrial Uses Of Glycerin
-
Chinese herbal medicine traceability system construction blueprint more clearly
-
These policies will affect all pharmaceutical companies!
-
Brazil sets up a special team to increase its own raw materials
-
Update of negative list of foreign investment access
-
Analysis of Hot Varieties in Antiviral Raw Material Market
-
API China:Stimulate industry innovation vitality
-
Raffles Pharma and Xuancheng Menova Pharmaceuticals reached a cooperation
-
2019 CPhI Worldwide Recap
Recommend Reading
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Novavax COVID-Flu Vaccine Shows Strong Immune Response in Trial
-
This Week's Caustic Soda Prices Consolidate (5.18-5.22)
-
Supply-Demand Dynamics Drive Slight Rise in Toluene Market
-
Supply Increases in Stages, China’s Acrylonitrile Market Slips Narrowly
-
Under a Triple Game, Polyethylene Operates with a Weak and Fluctuating Trend
-
Ashland Advances $60 Million Strategic Manufacturing Network Optimization